DC vaccination for HIV

To treat HIV-infected individuals, one approach is therapeutic vaccination that aims to induce durable immunity by reactivating the individual’s immune system to HIV. Ideally, this would lead to viral control without taking combined anti-retroviral therapy (cART).

In this project, we examine several cohorts with -omics technology to try and understand the effect that these DC vaccinations have on vaccinated individuals.


DC immunotherapy in HIV-1 infection induces a major blood transcriptome shift

PDF Dataset Project